Computer Aided Clinical Trials for Implantaule Cardiac Devices

Area of Science:

• Biomedical Engineering
• Computational Physiology
• Medical Device Evaluation

Background:

• Traditional clinical trials for implantable medical devices are lengthy, expensive, and have high failure rates.
• The Rhythm ID Goes Head-to-head Trial (RIGHT) for implantable cardioverter defibrillators exemplifies these challenges, costing significant resources over five years.
• Evaluating life-critical devices necessitates more efficient and reliable methods than conventional clinical testing.

Purpose of the Study:

• To demonstrate how modeling and simulation of physiological systems can effectively evaluate life-critical implantable medical devices.
• To introduce and validate a Computer-aided Clinical Trial (CACT) framework for implantable cardiac devices.
• To compare the performance of CACT with traditional trial methodologies using a specific case study.

Main Methods:

• Development of a Computer-aided Clinical Trial (CACT) integrating prior trial data, real patient information, and closed-loop device models.
• Formulation of the CACT within a Bayesian statistical framework, utilizing a hierarchical model of a virtual cohort derived from a physiological model.
• Incorporation of parameter uncertainty and available design information into the model for robust evaluation.

Main Results:

• The CACT accurately estimated the inappropriate therapy rate for Vitality 2 versus Medtronic at 33.22% vs 15.62% (p<0.001).
• These results were comparable to the outcomes of the original RIGHT clinical trial.
• The study demonstrated the feasibility and reliability of using CACT for device evaluation.

Conclusions:

• Computer-aided Clinical Trials (CACT) provide a high-confidence, efficient alternative for evaluating implantable cardiac devices.
• Physiological system modeling and simulation can significantly improve the evaluation process for life-critical medical technologies.
• CACT offers a promising direction for reducing the cost, time, and ethical burden of medical device clinical trials.